Costotransverse Foramen Block vs Thoracic Paravertebral Block in Thoracotomy Pain Management
Costotransverse foramen block
+ Thoracic paravertebral plane block
Lung Diseases+4
+ Lung Neoplasms
+ Neoplasms
Treatment Study
Summary
Study start date: January 24, 2026
Actual date on which the first participant was enrolled.Thoracotomy, a type of surgery for lung cancer, is known to be one of the most painful procedures. Around 75% of patients experience moderate to severe pain after the surgery. To manage this pain, doctors use various techniques such as thoracic epidural analgesia (TEA), thoracic paravertebral block (TPVB), and erector spinae plane block (ESPB). TEA, once considered the best method, has side effects that prompted researchers to explore other options. One such alternative is the costotransverse foramen block (CTFB), a recently introduced technique that has shown promise in both cadaveric and case studies. This study aims to find a safer and more effective method to manage post-thoracotomy pain. During the study, participants will receive either a CTFB or a TPVB. If a patient's pain level, measured on a visual analog scale (VAS), reaches 4 or higher, they will be given a 4 mg bolus of morphine as a rescue analgesic. The study's primary outcome is to measure the total amount of morphine consumed by each patient. This will help determine which technique, CTFB or TPVB, is more effective in managing pain after thoracotomy.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.70 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location